Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.25%||162.64||0.7%||$1229.36m|
|MRK||Merck & Co., Inc.||0.18%||77.61||0.7%||$782.74m|
|BMY||Bristol-Myers Squibb Co.||0.44%||65.75||1.0%||$703.61m|
|LLY||Eli Lilly & Co.||0.25%||189.73||1.1%||$539.14m|
|RPRX||Royalty Pharma Plc||-0.24%||41.77||0.2%||$91.76m|
|NVO||Novo Nordisk A/S||0.75%||72.71||0.1%||$62.90m|
Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.